ArticleBioinformatics (Oxford, England)2026
MuFaDDG: a sequence-based multiscale feature fusion framework for protein stability changes prediction.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationPredicting the thermodynamic stability of proteins upon single-point mutations is a pivotal step in both protein engineering and medicine. In the study of predicting protein thermodynamic stability, various computational methods, whether they extract features at the local-level or global-level, exhibit their respective advantages and limitations. To leverage the advantages of both features, we developed MuFaDDG, a novel sequence-based method that integrated multiscale feature fusion for improved prediction of protein stability changes (ΔΔG).
resultsMuFaDDG achieves comparable performance on the S669 benchmark, demonstrating strong capabilities in stabilizing mutations. Notably, it shows a significant advantage in the ACC metric, with values of 0.75, 0.88, and 0.81 on the direct, reverse, and overall datasets of the CAGI5 Challenge's Frataxin, respectively. Furthermore, our method outperforms leading sequence-based approaches including THPLM, DDGemb, DDGun, and INPS-Seq on protein Myoglobin stability prediction. Additionally, MuFaDDG demonstrates exceptional predictive performance with higher PCC and ACC on the protein ThreeFoil, which is uncurated by FireProtDB and ProThermDB databases. AVAILABILITY AND IMPLEMENTATION: The source code and data are available at https://github.com/PengjiaMa23/MuFaDDG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.